Unlock instant, AI-driven research and patent intelligence for your innovation.

Quinolinyl and benzothiazolyc PPAR-gamma modulators

An alkyl and aryl technology, applied in the field of regulating PPARγ receptors, can solve problems such as side effects that limit clinical use

Inactive Publication Date: 2003-08-27
AMGEN INC
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Despite the progress of the thiazolidinedione family of antidiabetic drugs, unacceptable side effects limit their clinical use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quinolinyl and benzothiazolyc PPAR-gamma modulators
  • Quinolinyl and benzothiazolyc PPAR-gamma modulators
  • Quinolinyl and benzothiazolyc PPAR-gamma modulators

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0070] Compound preparation

[0071] The compounds of the invention can be prepared using standard synthetic methods. Schemes 1-3 illustrate exemplary methods for preparing compounds of formula (Ia). Those skilled in the art will understand that compounds of other structural types can be synthesized in a similar manner.

[0072] Preparation of compounds

[0073] As shown in Scheme 1, compounds of the present invention can be prepared starting from commercially available 2-chloro-5-nitrobenzonitrile (i) with phenol, thiophenol or optionally protected aniline in the presence of base and heat Subsequent treatment of i affords the adduct (ii). with H 2 Reduction of the nitro group in ii in the presence of Raney nickel catalyst affords the aniline derivative (iii). With a suitable arylsulfonyl halide (Ar 1 SO 2 Cl) Sulfonation of iii in the presence of a base (usually a tertiary amine) yields the target compound (iv). Compound iii can also be transformed into related compo...

Embodiment 1

[0110] The following benzenesulfonyl chlorides were prepared from the corresponding commercially available anilines by the method of R.V. Hoffman (Org. Syn. Col. Vol. VII, 508-511) for carrying out the given examples.

[0111] 2-Chloro-4-tert-butylbenzenesulfonyl chloride (1a). Yield 34%. 1 H NMR (CDCl 3 ) δ8.06 (1H, d, J = 8.4Hz), 7.62 (1H, s), 7.48 (1H, d, J = 8.4Hz), 1.37 (9H, s); melting point 68.8°C.

[0112] 2-Trifluoromethyl-4-chlorobenzenesulfonyl chloride (1b). Yield 76%, solid. 1 H NMR (CDCl 3 ) 8.325 (d, J=8.4Hz, 1H), 7.966 (br s, 1H), 7.829 (br d, J=8.4Hz, 1H). Melting point 37.0℃

[0113] e-Chloro-4-methylbenzenesulfonyl chloride (1c). Yield 47%, oil. 1 H NMR (CDCl 3 ) 8.02 (1H, d, J = 8.8Hz), 7.46 (1H, s), 7.28 (1H, d, J = 8.8Hz), 2.47 (3H, s).

Embodiment 2

[0115] 2.1 2.2 2.3

[0116] Compound 2.3

[0117] Compound 2.1 was prepared by adapting the published method of Albert and bArlin (J. Chem. Soc. 2384-2396 (1959)). 3-Aminoquinoline (15.0 g, 105 mmol) was suspended in a mixture of 10N HCl (40 mL), ice (21 g) and water (100 ml) at 0-5°C, then sodium nitrite (7.6 g, 110 mmol) was added slowly. The mixture was then added in portions to another solution of potassium ethyl xanthate (20.8 g, 125 mmol) in water (60 ml) at 45°C. Heat to mix for 1 hour then cool. The mixture was then extracted with ether. The ether solution was washed with 2N NaOH solution, water and brine, then dried over magnesium sulfate. After filtration, the solvent was removed to give a brown oil (15g), which was then dissolved in ethanol (150ml) and refluxed with KOH (25g) under nitrogen overnight. The ethanol solvent was then removed in vacuo and the residue was partitioned between water and ether. The ether solution was discarded. The aqueous solution ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

Compounds having the formula (I) wherein Ar<1> is substituted or unsubstituted 2-benzothiazolyl or substituted or unsubstituted quinolinyl; X is -O-, -C(O)-, -CH(R<10>)-, -N(R<11>)-, or -S(O)k-; Y is -N(R<12>)-S(O)2-; R<1> is hydrogen or a specified substituent; R<2> is substituted or unsubstituted aryl; and R<3> is halogen or (C1-C8)alkoxy are useful in the treatment or prevention of a condition or disorder mediated by PPAR gamma . In particular, the compounds of the invention modulate the function of PPAR gamma . The subject methods are particularly useful in the treatment and / or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of U.S. Provisional Application Serial No. 60 / 214,810, filed June 28, 2000, and U.S. Patent Application No. 60 / 073,042, filed January 29, 1998, and U.S. Patent Application No. 60 / 073,042, filed January 20, 1999 No. 09 / 234,327, now US Patent No. 6,200,995. This application is also related to U.S. Patent Application No. 60 / 141,672, filed June 30, 1999, U.S. Patent Application No. 09 / 606,433, filed June 28, 2000, and PCT Application No. US00 / 18178, filed June 28, 2000 , now PCT Publication No. WO 01 / 00579, the disclosures of each of which are hereby incorporated by reference in their entirety. field of invention [0003] The present invention relates to modulation of PPARγ receptors for use in the diagnosis and treatment of type II diabetes (and its complications), hypercholesterolemia (and diseases associated with abnormally high or low plasma lipoprotein or triglyceride levels) and inf...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/428A61K31/4439A61K31/47A61K31/4725A61K31/506A61P3/00A61P3/04A61P3/06A61P3/10A61P9/10A61P19/02A61P29/00A61P43/00C07D215/12C07D215/20C07D215/36C07D215/48C07D277/64C07D277/68C07D277/82C07D417/04C07D417/12C07D417/14
CPCC07D417/14C07D277/68C07D417/04C07D215/12C07D277/82C07D215/20C07D215/36C07D417/12C07D277/64C07D215/48A61P19/02A61P29/00A61P3/00A61P3/04A61P3/06A61P43/00A61P9/10A61P3/10
Inventor L·R·姆克吉J·B·乌泽S·M·鲁本斯坦新海久古川昇荻原笃
Owner AMGEN INC